The Enterprise Value as of December 2024 (TTM) for Mersana Therapeutics, Inc. (MRSN) is 141.64M

According to Mersana Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 141.64M. This represents a change of -45.14% compared to the average of 258.20M of the last 4 quarters.

Mersana Therapeutics, Inc. (MRSN) Historical Enterprise Value (quarterly & annually)

How has MRSN Enterprise Value performed in the past?

The mean historical Enterprise Value of Mersana Therapeutics, Inc. over the last ten years is 323.03M. The current 141.64M Enterprise Value has changed 4.28% with respect to the historical average. Over the past ten years (40 quarters), MRSN's Enterprise Value was at its highest in in the December 2020 quarter at 1.58B. The Enterprise Value was at its lowest in in the June 2017 quarter at -13323057.24.

Mersana Therapeutics, Inc. (MRSN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Mersana Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mersana Therapeutics, Inc. (MRSN) Average Enterprise Value

How has MRSN Enterprise Value performed in the past?

The current Enterprise Value of Mersana Therapeutics, Inc. (MRSN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Mersana Therapeutics, Inc. (MRSN) Enterprise Value vs. Peers

How is MRSN’s Enterprise Value compared to its peers?

Mersana Therapeutics, Inc.’s Enterprise Value is less than Terns Pharmaceuticals, Inc. (234.86M), less than Amylyx Pharmaceuticals, Inc. (209.72M), greater than Acumen Pharmaceuticals, Inc. (103.15M), less than Inozyme Pharma, Inc. (215.58M), greater than X4 Pharmaceuticals, Inc. (79.21M), less than Day One Biopharmaceuticals, Inc. (859.59M), greater than HOOKIPA Pharma Inc. (-37325309.00), greater than Theseus Pharmaceuticals, Inc. (138.26M), less than Cullinan Oncology, Inc. (591.52M), less than Relay Therapeutics, Inc. (623.90M), less than Arcus Biosciences, Inc. (1.32B), less than Kura Oncology, Inc. (662.36M), less than Protagonist Therapeutics, Inc. (2.30B), less than Merus N.V. (2.48B), less than Replimune Group, Inc. (892.33M), less than Cerevel Therapeutics Holdings, Inc. (8.24B), less than Pliant Therapeutics, Inc. (792.38M), less than Syndax Pharmaceuticals, Inc. (1.00B), less than Revolution Medicines, Inc. (7.90B), less than Viridian Therapeutics, Inc. (1.38B),

Build a custom stock screener for Mersana Therapeutics, Inc. (MRSN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mersana Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mersana Therapeutics, Inc. (MRSN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mersana Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.